Phase 2 trials of the Covid-19 vaccine developed by Oxford University began on Tuesday at India’s Bharati Vidyapeeth Medical College and Hospital in Pune. On Wednesday, 6 volunteers were administered a dose of the vaccine after their RT PCR and anti-body tests were cleared. The vaccine, named Covishield in India, is so far the most promising of the 150 vaccines being watched by the global community.
#CovidVaccine #OxfordVaccine #AstraZeneca
